- Home
- VRRM vs CLDX Comparison
VRRM vs CLDX Comparison
Compare VRRM & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VRRM | CLDX |
|---|---|---|
| Founded | 1987 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Transportation Services | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.1B |
| IPO Year | 2016 | 1995 |
Fundamental Metrics
Financial Performance| Metric | VRRM | CLDX |
|---|---|---|
| Price | $14.77 | $32.61 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 10 |
| Target Price | $25.90 | ★ $46.60 |
| AVG Volume (30 Days) | ★ 1.1M | 842.3K |
| Earning Date | 05-06-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 347.37 | N/A |
| EPS | ★ 0.85 | N/A |
| Revenue | ★ $132,969,000.00 | $12,743,000.00 |
| Revenue This Year | $6.84 | $111.39 |
| Revenue Next Year | $6.88 | $235.85 |
| P/E Ratio | $17.54 | ★ N/A |
| Revenue Growth | 14.61 | ★ 87.78 |
| 52 Week Low | $13.84 | $17.87 |
| 52 Week High | $25.83 | $35.83 |
Technical Indicators
Market Signals| Indicator | VRRM | CLDX |
|---|---|---|
| Relative Strength Index (RSI) | 42.73 | 51.01 |
| Support Level | $14.35 | $28.30 |
| Resistance Level | $15.55 | $34.52 |
| Average True Range (ATR) | 0.37 | 1.16 |
| MACD | 0.02 | -0.32 |
| Stochastic Oscillator | 14.37 | 22.73 |
Price Performance
Historical ComparisonAbout VRRM Verra Mobility Corporation
Verra Mobility Corp is a provider of smart mobility technology solutions, principally operating throughout the United States, Australia, Europe, and Canada. The company develops and uses technology and data intelligence to help make transportation safer and easier. It operates in three reportable segments: Commercial Services, Government Solutions, and Parking Solutions. Maximum revenue is generated from the Commercial Services segment, which offers toll and violation management solutions and title and registration services for commercial fleet customers, including RACs and FMCs in North America. In Europe, it provides tolling and violations processing services.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.